Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radical Prostatectomy in Oligo-Metastatic Prostate Cancer
NCT03988686Unknown
- Sponsor
- Fudan University
- Start
- Apr 2019
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Randomised, open-label trial in prostate cancer (PCa) (2 arms), sponsored by Fudan University. Primary endpoint: Time to Castrate Resistance at 36 months. Status: unknown.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03988686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03988686.